PT1097140E - Derivados de imidazole substituidos com bifenilsulfonilo processo para a sua preparacao sua aplicacao como medicamento ou meio de diagnostico asim como medicamento neles incluido - Google Patents
Derivados de imidazole substituidos com bifenilsulfonilo processo para a sua preparacao sua aplicacao como medicamento ou meio de diagnostico asim como medicamento neles incluidoInfo
- Publication number
- PT1097140E PT1097140E PT99934669T PT99934669T PT1097140E PT 1097140 E PT1097140 E PT 1097140E PT 99934669 T PT99934669 T PT 99934669T PT 99934669 T PT99934669 T PT 99934669T PT 1097140 E PT1097140 E PT 1097140E
- Authority
- PT
- Portugal
- Prior art keywords
- biphenylsulphonyl
- medicine
- preparation
- application
- medicinal product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dentistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19832429A DE19832429A1 (de) | 1998-07-18 | 1998-07-18 | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1097140E true PT1097140E (pt) | 2004-07-30 |
Family
ID=7874575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99934669T PT1097140E (pt) | 1998-07-18 | 1999-07-10 | Derivados de imidazole substituidos com bifenilsulfonilo processo para a sua preparacao sua aplicacao como medicamento ou meio de diagnostico asim como medicamento neles incluido |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6372917B1 (pt) |
| EP (1) | EP1097140B1 (pt) |
| JP (1) | JP4567884B2 (pt) |
| KR (1) | KR20010070984A (pt) |
| CN (1) | CN1177827C (pt) |
| AR (1) | AR019404A1 (pt) |
| AT (1) | ATE260901T1 (pt) |
| AU (1) | AU764784B2 (pt) |
| BR (1) | BR9912139A (pt) |
| CA (1) | CA2338039A1 (pt) |
| DE (2) | DE19832429A1 (pt) |
| DK (1) | DK1097140T3 (pt) |
| ES (1) | ES2217779T3 (pt) |
| HK (1) | HK1038352A1 (pt) |
| HU (1) | HUP0103184A3 (pt) |
| ID (1) | ID27023A (pt) |
| MX (1) | MXPA01000534A (pt) |
| PL (1) | PL346165A1 (pt) |
| PT (1) | PT1097140E (pt) |
| RU (1) | RU2246489C2 (pt) |
| TR (1) | TR200100123T2 (pt) |
| WO (1) | WO2000003994A2 (pt) |
| ZA (1) | ZA200100318B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| KR20030024259A (ko) * | 2001-09-17 | 2003-03-26 | 주식회사케이텍정보통신 | 도로통행료 징수 시스템 |
| US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
| US20030220383A1 (en) * | 2002-02-14 | 2003-11-27 | Aventis Pharma Deutschland Gmbh | Use of inhibitors of the sodium-dependent chloride/bicarbonate exchanger for the treatment of thrombotic and inflammatory disorders |
| US7531569B2 (en) * | 2003-12-02 | 2009-05-12 | Sanofi-Aventis Deutschland Gmbh | Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| DE10356717A1 (de) * | 2003-12-02 | 2005-07-07 | Aventis Pharma Deutschland Gmbh | Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| EP0503838A3 (en) * | 1991-03-08 | 1992-10-07 | Merck & Co. Inc. | Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists |
| CA2109524A1 (en) * | 1991-05-10 | 1992-11-11 | Prasun K. Chakravarty | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
| TW215434B (pt) * | 1992-03-07 | 1993-11-01 | Hoechst Ag | |
| US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| FR2711367B1 (fr) * | 1993-10-19 | 1995-12-01 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2711368B1 (fr) * | 1993-09-16 | 1996-01-05 | Roussel Uclaf | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
| FR2716882B1 (fr) | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
| FR2716883B1 (fr) * | 1994-03-04 | 1996-04-26 | Roussel Uclaf | Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant. |
| DE19540995A1 (de) * | 1995-11-03 | 1997-05-07 | Hoechst Ag | Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| EP0855392A3 (de) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832429A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1998
- 1998-07-18 DE DE19832429A patent/DE19832429A1/de not_active Withdrawn
-
1999
- 1999-07-10 ES ES99934669T patent/ES2217779T3/es not_active Expired - Lifetime
- 1999-07-10 HU HU0103184A patent/HUP0103184A3/hu unknown
- 1999-07-10 MX MXPA01000534A patent/MXPA01000534A/es not_active IP Right Cessation
- 1999-07-10 KR KR1020017000751A patent/KR20010070984A/ko not_active Application Discontinuation
- 1999-07-10 EP EP99934669A patent/EP1097140B1/de not_active Expired - Lifetime
- 1999-07-10 PL PL99346165A patent/PL346165A1/xx not_active Application Discontinuation
- 1999-07-10 US US09/743,941 patent/US6372917B1/en not_active Expired - Lifetime
- 1999-07-10 CA CA002338039A patent/CA2338039A1/en not_active Abandoned
- 1999-07-10 WO PCT/EP1999/004886 patent/WO2000003994A2/de not_active Application Discontinuation
- 1999-07-10 DE DE59908753T patent/DE59908753D1/de not_active Expired - Lifetime
- 1999-07-10 AU AU50364/99A patent/AU764784B2/en not_active Ceased
- 1999-07-10 JP JP2000560101A patent/JP4567884B2/ja not_active Expired - Fee Related
- 1999-07-10 TR TR2001/00123T patent/TR200100123T2/xx unknown
- 1999-07-10 CN CNB998086967A patent/CN1177827C/zh not_active Expired - Fee Related
- 1999-07-10 RU RU2001104454/04A patent/RU2246489C2/ru not_active IP Right Cessation
- 1999-07-10 BR BR9912139-5A patent/BR9912139A/pt not_active IP Right Cessation
- 1999-07-10 AT AT99934669T patent/ATE260901T1/de not_active IP Right Cessation
- 1999-07-10 PT PT99934669T patent/PT1097140E/pt unknown
- 1999-07-10 DK DK99934669T patent/DK1097140T3/da active
- 1999-07-10 ID IDW20010128A patent/ID27023A/id unknown
- 1999-07-15 AR ARP990103485A patent/AR019404A1/es not_active Application Discontinuation
-
2001
- 2001-01-11 ZA ZA200100318A patent/ZA200100318B/en unknown
- 2001-12-27 HK HK01109111A patent/HK1038352A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0103184A3 (en) | 2002-05-28 |
| DE59908753D1 (de) | 2004-04-08 |
| BR9912139A (pt) | 2001-04-10 |
| WO2000003994A2 (de) | 2000-01-27 |
| EP1097140B1 (de) | 2004-03-03 |
| DK1097140T3 (da) | 2004-05-24 |
| AU5036499A (en) | 2000-02-07 |
| ZA200100318B (en) | 2002-04-11 |
| HUP0103184A2 (hu) | 2002-04-29 |
| ATE260901T1 (de) | 2004-03-15 |
| TR200100123T2 (tr) | 2001-05-21 |
| WO2000003994A3 (de) | 2000-04-20 |
| CN1309644A (zh) | 2001-08-22 |
| DE19832429A1 (de) | 2000-01-20 |
| RU2246489C2 (ru) | 2005-02-20 |
| AR019404A1 (es) | 2002-02-20 |
| US6372917B1 (en) | 2002-04-16 |
| HK1038352A1 (en) | 2002-03-15 |
| EP1097140A2 (de) | 2001-05-09 |
| PL346165A1 (en) | 2002-01-28 |
| MXPA01000534A (es) | 2002-06-04 |
| ID27023A (id) | 2001-02-22 |
| AU764784B2 (en) | 2003-08-28 |
| CA2338039A1 (en) | 2000-01-27 |
| JP4567884B2 (ja) | 2010-10-20 |
| JP2002520397A (ja) | 2002-07-09 |
| CN1177827C (zh) | 2004-12-01 |
| ES2217779T3 (es) | 2004-11-01 |
| KR20010070984A (ko) | 2001-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9704483A (pt) | Guanididas de ácido alquenilcarboxílico fenil-substituídas processo para sua preparação sua utilização como medicamento ou meio de diagnóstico e medicamento que as contêm | |
| FR2737118B1 (fr) | Composition dermatologique ou pharmaceutique, procede de preparation et utilisation | |
| MA23560A1 (fr) | Procede de preparation de derives de quinoline et utilisation de ces derives dans la production des medicaments | |
| DE69820108D1 (de) | Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien | |
| BR9507700A (pt) | Novos derivados da eritromicida proceso de preparação dos mesmos e aplicação dos mesmos como medicamentos | |
| EE9700145A (et) | Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid | |
| MA23528A1 (fr) | Procede de preparation de produits pharmaceutiques | |
| ATE236119T1 (de) | Phenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende mittel | |
| ATE232543T1 (de) | 11beta-halogen-7alpha-substituierte-estratriene verfahren zur herstellung pharmazeutischer präparate, die diese 11beta-halogen-7alpha- substituierte-estratriene enthalten, sowie deren verwendung zur herstellung von arzneimitteln | |
| AR002039A1 (es) | Pirido[3.2-e]pirazinonas con efecto antiasmatico, y procedimiento para su preparacion y los medicamentos que los contienen y su preparación | |
| AR010399A1 (es) | DERIVADOS DE AMIDAS DE LOS ÁCIDOS ISOXAZoLICO Y CROToNICO , PROCEDIMIENTO PARA SU PREPARACIoN MEDICAMENTO QUE LOS CONTIENE Y SU UTILIZACIoN COMO MEDICAMENTOS Y COMO AGENTES DE DIAGNoSTICO | |
| BR9605417A (pt) | Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas | |
| PT1097140E (pt) | Derivados de imidazole substituidos com bifenilsulfonilo processo para a sua preparacao sua aplicacao como medicamento ou meio de diagnostico asim como medicamento neles incluido | |
| MA23518A1 (fr) | Procede de preparation de produits pharmaceutiques | |
| EE9500020A (et) | Kinoloon- ja naftüridoonkarboksüülhapped ja nende derivaadid, nende valmistamismeetodid ja nimetatud ühendeid sisaldavad ravimid | |
| BR9703338A (pt) | 2-Naftoil guanidinas substituídas processo para a sua preparaçao sua aplicaçao como medicamento ou diagnóstico bem como medicamento que as contêm | |
| FI953173A0 (fi) | Orto-aminosubstituoituja bentsolyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine | |
| EE9600023A (et) | Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod | |
| FI102169B1 (fi) | 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina | |
| ATE189896T1 (de) | 17-alpha-unsubstituierte pregnan derivate, ihre verwendung als medikamente, ein verfahren zu ihrer herstellung und zwischenprodukte dieses verfahrens, und pharmazeutische präparate davon | |
| PT913396E (pt) | Derivados de benzopiranos substituidos com sulfonamida processo para a sua preparacao sua utilizacao como medicamento bem como preparacoes farmaceuticas que as contem | |
| DE3674521D1 (de) | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte. | |
| BR9610851A (pt) | Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto | |
| FI955614A (fi) | Substituoidut bentsoyyliguanidiinit, menetelmä niiden valmistamiseksi,niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisäl tävä lääkeaine | |
| FI960688A0 (fi) | Substituoituja bentseenisulfonyyliureoita ja -tioureoita, menetelmä niiden valmistamiseksi ja näihin yhdisteisiin perustuvien farmaseuttisten valmisteiden käyttö sekä niitä sisältäviä lääkkeitä |